Gurleen Kaur, MD Profile
Gurleen Kaur, MD

@Gurleen_Kaur96

4,332
Followers
2,067
Following
464
Media
2,817
Statuses

Cardiology Fellow @BrighamFellows via @BrighamMedRes & @AlbanyMed | Academy APD @CardioNerds

Boston, MA
Joined February 2020
Don't wanna be here? Send us removal request.
Pinned Tweet
@Gurleen_Kaur96
Gurleen Kaur, MD
9 months
So excited to be joining @BrighamFellows next year for Cardiology! 🫀 Incredibly grateful to all my mentors at @AlbanyMed @BrighamMedRes @CardioNerds & many others for all their support and guidance over the years!
Tweet media one
66
16
852
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
1/ Ready for a #Tweetorial on coronary artery calcium (CAC) score? Keep reading to: ☢️Understand the pathophysiology of coronary artery calcium ☢ Identify the utility of the CAC score ☢️Recognize the limitations of CAC scoring
Tweet media one
62
354
1K
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Still can’t believe I matched to Brigham for #internalmedicine - truly a dream come true!!! Beyond excited to embark on this next phase of my journey in medicine! @BrighamWomens @BrighamMedRes
Tweet media one
59
5
579
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Officially Dr. Gurleen Kaur, MD! Grateful for my family, friends, teachers, and mentors who have supported me throughout this journey!
Tweet media one
47
8
465
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
1/ Cardiac Stress Testing @CardioNerds 🔶Indications 🔶Types - Exercise vs. Pharmacological 🔶Compare & Contrast Modalities Thanks to @SimratKaurMD , @AmitGoyalMD , @jholtzman3 for feedback on this infographic! Follow🧵for a breakdown of the graphic⤵️
Tweet media one
13
148
437
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Approach to diuretic resistance⤵️ Listen to @CardioNerds Ep153 for an enlightening discussion on the topic: Many thanks to @EvelynSongMD , @AmitGoyalMD , @Dr_DanMD , @karanpdesai , @captainchloride , @Nephro_Sparks for feedback on this infographic!
Tweet media one
3
144
397
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
💥The Ultimate Guide to Lipids💥 🟢Lipid biology 🟢Physical exam clues for lipid disorders 🟢Lipid tests & interpretation 🟢CV risk assessment 🟢Fundamentals of lipid management 🟢Review of guidelines 🧵on this great @ACCinTouch session from today #ACC21 #ACCMedStudent #ACCPrev
Tweet media one
5
128
346
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Currently on Nephrology consult and realized I didn't have an approach to renal infarction, so schema it is... #MedTwitter and @CPSolvers fam - feedback appreciated!
Tweet media one
6
64
327
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
I matched! #IMProud #internalmedicine Couldn't have gotten to this point without the support of my family, friends, and mentors! So so grateful. Here's to soon becoming the first doctor in my family.
Tweet media one
43
1
308
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Summary of Stage D (Advanced) Heart Failure based on the 2022 AHA/ACC/HFSA Guidelines ⤵️ @CardioNerds Thanks to @TDonisan , @AmitGoyalMD , @EuniceDuganMD , @jholtzman3 for feedback on this infographic!
Tweet media one
8
100
293
@Gurleen_Kaur96
Gurleen Kaur, MD
10 months
I first learned about the NEJM Clinical Problem-Solving cases during 3rd yr of med school from @rabihmgeha & @DxRxEdu on @CPSolvers VMR! Grateful to have had the opportunity to author this CPS case, now out in @NEJM 🫀 🔗
Tweet media one
@NEJM
NEJM
10 months
A 75-year-old man with a history of atrial tachyarrhythmias, tricuspid regurgitation, and pericarditis presented with worsening dyspnea, leg swelling, and abdominal bloating after recent catheter ablation. Read about the case:
0
10
44
17
29
286
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
🥊Cardiology vs Nephrology🥊 🎙️ @CardioNerds Ep 154: A Diuretic Showdown w/ Dr. Felker ( @DukeHFDoc ) & Dr. Sparks ( @Nephro_Sparks ), moderated by @kellyarps ➡️Approach to volume overload and diuretic strategies #HeartSuccess 🔗
Tweet media one
Tweet media two
6
78
235
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Excited to be a part of the ACC Women’s Internal Medicine Cardiology Program! Looking forward to the virtual launch this week and to meet in-person at #ACC22 Thank you for the gift 😊 @DrQuinnCapers4 @MelvinEchols9 @melsulistio @HFnursemaghee @ACCinTouch
Tweet media one
15
5
215
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Great @JACCJournals review on mechanisms of cardiovascular benefits of SGLT2 inhibitors #CardsJC
Tweet media one
Tweet media two
2
58
201
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Essentials of Stable Ischemic Heart Disease ♦️Plaque Characteristics & Progression ♦️Choosing From Imaging Toolbox ♦️Perils of Polypharmacy ♦️Who & When To Revascularize ♦️Overview of Guidelines 🧵on this great @ACCinTouch session from today #ACC21 #ACCMedStudent
Tweet media one
3
53
196
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Made a schema for hemoptysis after @CPSolvers Student VMR66. Great case presented by @AndreaAnampaG . Fantastic discussion by @dereckwpaul and Brianna! Please give feedback!
Tweet media one
3
36
184
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
16/ Also check out the following infographic comparing and contrasting CAC score and CCTA Thanks to the @cardionerds team for guidance and feedback, especially @EvelynSongMD & @karanpdesai
Tweet media one
9
36
176
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Finished first week of intern yr on Cards nights! Cardiology is 🤩🤩 My co-interns are amazing - so kind, smart, & down to earth Senior residents = role models Excellent teachers, always supportive, & so calm in times of emergencies Grateful to be a part of @BrighamMedRes
0
1
175
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Excited to share our JACC Advances article - Building Support to Increase Representation of Women in Cardiology: The Trainee Perspective, with 🌟 med students @AGandhi88 & @AdrianaCMares and mentorship from @KTamirisaMD & @gina_lundberg @JACCJournals
Tweet media one
11
55
173
@Gurleen_Kaur96
Gurleen Kaur, MD
7 months
Our review on Omega-3 fatty acids for cardiovascular event lowering, now out in @ESC_Journals 🔗 Thank you @DLBHATTMD for your mentorship!
Tweet media one
7
44
171
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Excited to be in NOLA soon for #ACC23 ! Looking forward to presenting our moderated poster on sex differences in Lp(a) & CV outcomes in the MGB Lp(a) Registry Thanks to @RonBlankstein for his mentorship and to the entire team @adambermanmd @Bweber04 @mdicarli @DLBHATTMD
Tweet media one
13
10
168
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Created this illness script for endocarditis after encountering the diagnosis so many times on @CPSolvers #VMR ! As always, feedback is appreciated!
Tweet media one
4
35
163
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
When to use CAC score🆚coronary CTA? Pros and cons of each anatomic test? Check out this infographic and listen to @cardionerds Ep44 for more on CAC: Many thanks to @EvelynSongMD for all the guidance and @AmitGoyalMD @Dr_DanMD @karanpdesai for feedback
Tweet media one
4
51
159
@Gurleen_Kaur96
Gurleen Kaur, MD
5 months
Excited to share our review article on Lp(a): Emerging Insights & Therapeutics in @AJPCardio Thanks to mentors & co-authors @Bweber04 @RonBlankstein @garshick @adambermanmd 🔗
Tweet media one
4
21
147
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Great night float episode by @UnremarkableLab yesterday. We discussed Mobitz type 2 block, so here's what I came across for causes. #MedTwitter , feedback appreciated!
Tweet media one
4
20
123
@Gurleen_Kaur96
Gurleen Kaur, MD
11 months
Thanks to @SCAI for the opportunity to present this case from the Brigham CICU at the #SCAISHOCK meeting Couldn't have done it without the guidance of @Ajar_Kochar and @AmitGoyalMD !
Tweet media one
8
14
125
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Reasoning out loud with @CPSolvers is an experience like none other! Post-VMR cognitive autopsy helped me identify some knowledge gaps on pulm HTN. Thank you @ABRezMed for this interesting case and @ArsalanMedEd , @Sharminzi , @nsrosenberg for guiding me throughout the discussion!
Tweet media one
6
25
123
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
6/ ⁉️ When to use CAC ⁉️ Most evidence to help risk-stratify and aid in statin therapy decision ✅w/o DM & with LDL-C ≥70-189 ✅10-yr ASCVD risk of 5%-20% (borderline-intermediate risk group) NOT useful for pts with low risk (ASCVD <5%) or high risk (ASCVD >20%)
Tweet media one
2
25
120
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
🌟Future of Dyslipidemia Management🌟 🧵on this great session from #ACC21 #ACCMedStudent 1/ Team-based approach to improve CV outcomes 🔸pharmacist interventions reduce LDL-C 🔸sessions with dietitian improves lipids &📉costs 🔸Multi-D lipid clinic⬆️guideline-directed treatment
Tweet media one
1
35
118
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Reflected on the case from @CPSolvers VMR 65 Inspired by @DxRxEdu @rabihmgeha Would love feedback @jackpenner @haematognomist
Tweet media one
4
28
116
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
Excited to share that the research project I worked on in undergrad/medical school & presented at AHA 2018 is finally published! 🔗
Tweet media one
10
5
114
@Gurleen_Kaur96
Gurleen Kaur, MD
11 months
1/ Learned a lot by working on this review on "The Changing Epidemiology of the Cardiac Intensive Care Unit" with @ddbergMD ! 🔗 🧵summarizing some key points ⤵️
Tweet media one
4
24
107
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Learned a lot by working on this review article with my mentors at Albany Med in collaboration with @EugeniaGianos ⤵️Challenges in Optimizing Lipid Management in Women 🔗
Tweet media one
10
23
103
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Thank you @CPSolvers !! ❤️
@CPSolvers
The Clinical Problem Solvers
2 years
#MedTwitter , join us in wishing @Gurleen_Kaur96 an absolutely SUPERB birthday!! 🎉🎂
Tweet media one
3
2
47
18
0
99
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Our #AHA22 poster about the @CardioNerds & @PaChapterACC Narratives in Cardiology Tweetorials - Utilizing Social Media to Elevate Discussions on D&I Thanks to @karanpdesai , @ThomasMDas , @ZSharalayaMD , @TxID_Edu , @Dr_DanMD , Dr. Ghobrial, @noshreza , @KBerlacher , & @AmitGoyalMD !
Tweet media one
6
15
93
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
@rabihmgeha @DxRxEdu For dyspnea without hypoxia, I think of metabolic acidosis (ex: DKA), anemia, neuromuscular causes (ex: myasthenia), pericardial effusion, anxiety
0
12
90
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
Incredibly grateful for my mentors @RonBlankstein @Bweber04 Your support and guidance have been invaluable! Always inspired by your leadership #ASPC2023 #SCCT2023
Tweet media one
Tweet media two
3
3
91
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
4/ In the ️patient above, CAC score is useful to assess role for 1⁰ prevention meds like statins CAC is an active process: 🦴propagated by inflammation & mediators of oxidative stress 🦴affected by HLD & glucose CAC is an anatomic measure of calcific plaque burden
Tweet media one
2
9
88
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Tweet media one
2
8
85
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Last week, I got to meet these @CardioNerds and @CPSolvers #bossladies in person! 🤩🤩
Tweet media one
Tweet media two
6
5
87
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Presented our analysis at #AHA21 , on the inclusion of women in late-breaking clinical trials⤵️ Thanks to the team @jholtzman3 @JuliettePower44 @Dr_DanMD @AmitGoyalMD and grateful for @DrMarthaGulati 's mentorship! 🔗Abstract & Presentation:
Tweet media one
Tweet media two
Tweet media three
6
15
87
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
1/ Great #ASPC2021 session by @RonBlankstein on Chest Pain and Imaging Follow this🧵for some takeaways on 🟣Stress Testing vs. Anatomical Testing 🟣Coronary CTA 🟣Guidelines @ASPCardio @CardioNerds
Tweet media one
3
31
86
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
#MedTwitter - We have a new schema video for elevated Troponin! Thank you @CPSolvers for giving me the opportunity to narrate the video and @LindseyShipley8 @SZKamal @rabihmgeha @DxRxEdu for all your help!
3
21
86
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
2 weeks until #ASPC2023 ! 🫀 Excited to be a @CardioNerds Conference Scholar along with @ClaireCambron , @DrAlaaDiab & @HanchateShivani
Tweet media one
4
18
85
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
Excited to work with everyone in the @ACCinTouch Resident Leadership Group! #ACCMedRes
@joyfuldockemi
Yetunde Kemi Fatade, MD, MPH
1 year
The ACC Resident Leadership Group is excited to welcome this new cohort of Resident Leaders for the 2023-2024 year. We are inspired by their journeys, leadership, and passion for our shared love of cardiology, and we look forward to supporting their new initiatives and efforts!
Tweet media one
2
26
126
3
6
84
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
I’m excited to be a #ACCMedStudent Social Media Ambassador for #ACC21 ! Follow me from May 15 - 17 for updates.  @ACCinTouch
Tweet media one
11
6
83
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
1/ Strategies for medical management of obesity, presentation by @BevTchangMD #ASPC2023 Currently 5 meds FDA-approved for long term management of obesity ⤵️
Tweet media one
2
29
81
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
Excited to share our recent review article on Arsenic Exposure and Development of Atherosclerotic Cardiovascular Disease #CardioTwitter @karanpdesai @JDNewmanMDMPH @SripalBangalore
Tweet media one
6
6
82
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
First recording for the @CardioNerds series on GLP-1 agonists! A true masterclass on mechanisms of action w/ Dr. Dennis Bruemmer So much fun hanging out w/ @CFAndersenMD & @RichardAFerraro Stay tuned for new episodes of the Prevention series, in collaboration w/ @ASPCardio !
Tweet media one
0
11
81
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
1/ When to measure Lp(a) & what to do about it #ASPC2023 @HeartDocSadiya ACC/AHA guidelines: measure if intermediate risk ESC guidelines: family hx of premature CVD or reclassification in those borderline between moderate & high-risk. Also consider at least once in lifetime
Tweet media one
1
22
80
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
1/ Understanding obesity as a chronic condition #ASPC2023 @CardioNerds Great talk by Dr. Donna Ryans ⭐️ Cut points for BMI to define obesity are different in Asians
Tweet media one
4
22
80
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
1/ Case discussion #ASPC2023 CardioOb - severe hypertriglyceridemia in pregnancy For the case below, what would you recommend as 1st line therapy? ➡️statin? fibrate? low-fat diet? plasmapheresis?
Tweet media one
Tweet media two
Tweet media three
Tweet media four
3
29
81
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Revised version of @CardioNerds Cardiac Stress Testing infographic - thanks to feedback from @DrMarthaGulati , @purviparwani , & @AlliBigeh !
Tweet media one
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
1/ Cardiac Stress Testing @CardioNerds 🔶Indications 🔶Types - Exercise vs. Pharmacological 🔶Compare & Contrast Modalities Thanks to @SimratKaurMD , @AmitGoyalMD , @jholtzman3 for feedback on this infographic! Follow🧵for a breakdown of the graphic⤵️
Tweet media one
13
148
437
0
21
79
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
7/ CAC comes back as 0🎉 Power of Zero➡️defer statin! But what's the "warranty period" Powerful negative risk predictor, guidelines recommend rescan ~5-10 yrs More nuanced: 3-7 yr warranty w/ CAC = 0 in MESA study. Timing may be based on risk/comorbidities (age&diabetes)
Tweet media one
3
10
78
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Just re-listened to Monday's @CPSolvers VMR. Brilliant discussion by Erin, John, @AlexHorneMD , @jackpenner & great teaching points by @MariaMjaleman ! I had so much fun presenting this case! So many relevant schemas & illness scripts, but here's one by @CPSolvers
Tweet media one
2
12
76
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Thanks to @CardioNerds for powering this collaboration with future #WIC dream team & @DrMarthaGulati for your mentorship!
Tweet media one
@DrMarthaGulati
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦
2 years
Our review on #INOCA led by the brilliant @BreannaHansen_ & @jholtzman3 @Gurleen_Kaur96 @BhavyaVarma12 @karolinkaj @InocaInternati1 @CurrProbsCardio 💔INOCA associated with ⬆️ risk of MACE & ⬇️ QOL 💔less than 1/2 patients appropriately treated
Tweet media one
Tweet media two
Tweet media three
Tweet media four
5
71
214
3
19
75
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
1/ High-risk ethnicity: Focus on South Asians #ASPC2023 @dranandrohatgi South Asians have excess coronary disease risk Cardiometabolic risk ‼️ 🔗
Tweet media one
1
31
76
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
1/ Great case by @AnnKumfer at @CPSolvers Student VMR today Alpha-gal syndrome 🔸IgE antibody to galactose-α-1,3-galactose 🔸Delayed reaction (3-8 hrs) to red meat 🔸Associated w/ tick bites So much fun co-facilitating w/ @jackpenner & great discussion by @nilayansarkar & Ravi
Tweet media one
3
21
77
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
The community and friendships created through @CardioNerds are like none other! #AHA22 @PatrickZakka @a_h_ghoneem @JennaSkowronski @AmitGoyalMD
Tweet media one
2
11
74
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
1/ Lipoprotein(a) therapeutics in development, by @RonBlankstein #ASPC2023 🔺Currently, no available therapies that provide a large reduction in Lp(a) 🔺No clinical trial data that lowering Lp(a) leads to⬇️in CV events
Tweet media one
3
22
74
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
Thanks to @DrMarthaGulati for her inspiring leadership of @ASPCardio and for being such an amazing mentor #ASPC2023 @CardioNerds
Tweet media one
1
4
72
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
A special evening with these @CPSolvers & #VMR & #MedTwitter friends from 🇧🇷
Tweet media one
6
4
71
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Relevant trials prior to REVIVED ⤵️ #CardsJC There were major differences in patient population between trials so can not make direct comparisons
Tweet media one
@CardioNerdsJC
CardioNerds Journal Club
2 years
Didn’t get a chance to read REVIVED-BCIS2? Check out the visual abstract and article summary! #CardsJC
Tweet media one
0
15
32
2
22
72
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
Listen to the latest episode of @CardioNerds for a great discussion w/ @MKIttlesonMD on her book Mastering the Art of Patient Care Led by CardioNerds Academy Interns! And filled with pearls of wisdom #kittlesonrules 🎙️
Tweet media one
1
20
71
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Thanks to @LindseyShipley8 @SZKamal @kamal_mz @rabihmgeha @DxRxEdu for giving me the opportunity to narrate another @CPSolvers schema video! #MedTwitter , check out the video here for an approach to pneumothorax:
Tweet media one
1
12
71
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
12/ Let’s Summarize: CAC➡️highly specific feature of coronary atherosclerosis, use for borderline-intermediate risk pts CAC=0➡️very strong⛔️predictive value for future CV events CAC score ≥1,000➡️very aggressive LDL-C lowering ⚡️Limitations: can miss high risk features⚡️
5
6
68
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Excited to soon be in Chicago for #AHA22 ! Looking forward to presenting our poster on the @CardioNerds & @PaChapterACC Narratives in Cardiology series on Mon 11am CT in Zone 2 🫀 @AmitGoyalMD
Tweet media one
2
12
69
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
An honor to have @tony_breu share his expert tips & tricks on creating Tweetorials with the @CardioNerds ! Such an insightful discussion during this Academy Bootcamp session & we even got a sneak preview on his upcoming tweetorial topic... #MedTwitter stay tuned!🫀
Tweet media one
1
16
64
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
5/ How is CAC score calculated? Agatston CAC Score is based on a weighted density score – we measure volume of plaque and multiply by a density factor E.g: Lesion is 15 mm2 and 450 HU (Factor of 4), score is 60. All plaques are summed up to give a total score!
Tweet media one
2
10
69
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
The @NYSCACC Young Investigators Poster Session and Shark Tank Competition tonight at Coney Island Aquarium was so much fun! Had a great time presenting my #CardioObstetrics research project
Tweet media one
Tweet media two
9
10
68
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
So so grateful for the @CPSolvers family! I have grown so much over the past year thanks to @CPSolvers and VMR. Excited to officially be a part of this amazing team! 😊
@CPSolvers
The Clinical Problem Solvers
3 years
Hey #MedTwitter , we have wonderful news! We are so excited to welcome @Gurleen_Kaur96 to our CPSolvers family <3 You can learn more about Gurleen here:
Tweet media one
11
4
94
7
3
67
@Gurleen_Kaur96
Gurleen Kaur, MD
5 months
One of the best parts of #ACC24 - catching up with @CardioNerds friends!
Tweet media one
1
9
67
@Gurleen_Kaur96
Gurleen Kaur, MD
8 months
It’s been such a great experience working with @SinghSwaiman ’s team at 5 Rivers Heart Association this week! Their work focuses on not just healthcare but also education and environmental initiatives across Punjab
@SinghSwaiman
Dr. Swaiman Singh
8 months
Very proud to see @Gurleen_Kaur96 working with the 5 heart team on the ground in India. Her presence and talks will inspire and motivate many young girls. #womenincardiology
3
18
103
3
4
65
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
1/ Recent study led by @SalmanZahid in @JACCJournals investigated racial & socioeconomic disparities in CV outcomes of preeclampsia hospitalizations🤰🫀 🔗 And great editorial by @GarovicVesna & @agkattah 🧵on summary of findings
Tweet media one
3
21
64
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
9/ Is calcified plaque the whole story? No! High risk features of plaque 💥location, diffuseness, bifurcation 💥necrotic core, low-attenuation plaque 💥intraplaque hemorrhage 💥thin fibrous cap 💥positive remodeling 💥spotty micro-calcification 💥macrophage infiltration
2
4
63
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
The South Asian Cardiometabolic Curse?🫀 Article on @dranandrohatgi 's talk at #ASPC2023 in @mydocwire 🔗
Tweet media one
2
19
62
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Excited to share our article in @JACCJournals , with 🌟med students @sheth_samip & @AdrianaCMares , on diversifying the medical student pipeline into cardiology 🫀 #ACCMedStudent 🔗 Thank you @MelvinEchols9 for your response:
Tweet media one
6
18
61
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
8/ ☠️What about the opposite: CAC comes back as >1,000?☠️ CAC consortium study: 5x risk CVD, 2.8x risk all-cause mortality Current guidelines have high risk as CAC >300-400, but CAC >1,000 may be distinct group w/ risk similar/📈 than traditional secondary prevention pts
Tweet media one
4
11
61
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
Are you a medical student interested in Cardiology? 💕 @ACCinTouch is currently accepting applications for the #ACCMedStudent Leadership Group Great way to collaborate with a diverse group and implement new ideas and projects! Apply here:
Tweet media one
1
21
60
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
Chest Pain in Women: Considerations from the 2021 AHA/ACC Chest Pain Guideline ⤵️ Thank you @DrMarthaGulati for mentorship on this review article and co-authors @Deoliveiragdc & @FredRiveraMD ! 🔗 @CurrProbsCardio
Tweet media one
@FredRiveraMD
Frederick Berro Rivera, MD
1 year
Thankful for the opportunity to contribute to this very informative review. Learned a lot from the mentorship of @DrMarthaGulati 🙏🏽 @Gurleen_Kaur96 thank you!! @Deoliveiragdc @avolgman @Nishant_ShahMD
2
5
23
2
13
55
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
🧵on the top 10 breakthroughs in CVD in pregnancy & postpartum by @GarimaVSharmaMD 1) Pregnancy is a critical time period ⬆️ in maternal mortality recently #ACC23 / #WCCCardio #CardioNerds
Tweet media one
4
20
55
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Such an amazing @CardioNerds Nerding Out session with @SinghSwaiman ! Thank you for sharing your journey & global health work with us - your passion & purpose are inspiring!
Tweet media one
3
8
52
@Gurleen_Kaur96
Gurleen Kaur, MD
4 years
So grateful for the opportunity to join the amazing @cardionerds team as an Academy Intern and learn from these brilliant people! So excited for this perfect combo of all things Cardiology and #MedEd ! #ACCMedStudent
@CardioNerds
CardioNerds
4 years
INTRODUCING, the new class of ❤️ @cardionerds Academy Interns❤️, spaning pre-med to med student residency applicants: A hearty welcome to: @PrettiPimentaMD , @MaryamBMD , @Gurleen_Kaur96 , & Pacey Wetstein ❤️🤓 The #ACCFIT #CardioNerds future is bright☀️
Tweet media one
Tweet media two
6
12
55
12
4
54
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
Chronic inflammatory diseases - risk marker or risk factor? Great talk by @garshick at #ASPC2023 ⬆️ risk of CV outcomes in pts with RA, psoriasis, and SLE Observational data show that treatment of psoriasis reduces CV risk but RCTs of biologic therapy are inconclusive
Tweet media one
Tweet media two
Tweet media three
Tweet media four
2
14
53
@Gurleen_Kaur96
Gurleen Kaur, MD
1 year
1/ Understanding Lp(a) Measurement by @hsbhatia #ASPC2023 Lp(a) is made of apoB & apolipoprotein(a) ApoA is made of subunits of proteins that can have different # of repeats & therefore lead to heterogeneity in size of Lp(a) Assays that are isoform sensitive➡️affected by size
Tweet media one
1
13
52
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
11/ What if pt is on statin? Does CAC have prognostic utility? 2018 AHA/ACC guidelines: no clinical utility But CAC consortium retrospective analysis: ⬆️CAC w/ statins remains predictive of CVD mortality, though⬇️prognostic significance Statins may impact CAC density
Tweet media one
2
4
51
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Starting off #ACC23 / #WCCCardio with a session on Decoding the ABCs of the Cardiac ICU Diagnostic Tools in the CICU by @SarasVallabhMD What is fluid responsiveness? 15% ⬆️ in stroke volume in response to a 500cc bolus of IV fluid #CardioNerds
Tweet media one
1
15
52
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
One of the highlights of #AHA22 was meeting so many amazing #WIC ! @docbhardwaj & @KTamirisaMD , thanks for being so inspiring and sharing your wisdom! 🤩
Tweet media one
4
3
50
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
1/ Great #ASPC2021 session by @dramitkhera on ACS in Patients with COVID-19 Follow this🧵on pts w/ COVID 🔷Prevention of ACS events 🔷Identification of ACS 🔷Management of ACS @ASPCardio @CardioNerds
Tweet media one
3
17
51
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
“Tout moun se moun - Every person is a person” Just finished reading this inspiring book by @AaronLBerkowitz ! Thank you for sharing your honest reflections and reminding us to always advocate for each and every one of our patients.
Tweet media one
0
2
51
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
10/ Numerical CAC score can miss high-risk features Ex: spotty calcification ⬆️ in pts w/ ACS when plaques also show +tive remodeling & low-attenuation Some features can be assessed further by CT, OCT, IVUS ⬆️risk if >25% of the total score is in the left main coronary
Tweet media one
3
3
50
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Learned so much by being a part of this @CardioNerds episode on Family History of Premature ASCVD with @AnnMarieNavar , @a_h_ghoneem , @AmitGoyalMD , & @Dr_DanMD 🎙 And so many pearls in this infographic by @a_h_ghoneem ⤵️
Tweet media one
@AmitGoyalMD
Amit Goyal MD MAS
2 years
🎙️Proud to release @CardioNerds #210 - FHx of Premature ASCVD w/ @AnnMarieNavar , @Gurleen_Kaur96 , @a_h_ghoneem . 🔗 Inspired by this infographic by @a_h_ghoneem 👇🏽
Tweet media one
Tweet media two
2
18
51
0
11
48
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Podcasts 🌟Easily accessible & well-suited for time-constrained adult learners 🌟Can range from fundamental concepts to nuanced knowledge 🌟Vary in breadth & design, from clinical reasoning to interviews to primary literature to narratives 🌟Connection within larger community
Tweet media one
4
13
49
@Gurleen_Kaur96
Gurleen Kaur, MD
11 months
In this @CCCTNetwork analysis in @ESC_Journals , we assessed prognostic significance of hemodynamic parameters in pts w/ cardiogenic shock ⬇️systemic arterial tone & RV dysfunction were associated with mortality & systemic hypoperfusion @ddbergMD 🔗
Tweet media one
@CCCTNetwork
Critical Care Cardiology Trials Network
11 months
ICYMI from #CCCTN in @EHJACVCEiC led by @ddbergMD and @gurleen_kaur96 Prognostic Significance of Hemodynamic Parameters in Patients with Cardiogenic Shock
1
9
12
0
17
49
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
Loved learning from @jackpenner & @Sharminzi on today's @CPSolvers VMR! A short🧵on the diagnosis from the case I presented of a returning traveler from Panama What is myiasis❓ ➡️infection of fly larva in human tissue ➡️most common species is Dermatobia hominis (human botfly)
Tweet media one
1
19
47
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
#ACCMedStudent , it's Day 2 of #ACC21 ! Benefits of virtual meeting⏪old sessions available onDemand. Great @ACCinTouch session yesterday on Advanced Heart Failure Therapies, ending w/ debate on Transplant vs. LVAD! #ACCHFT 🧵on some take-home points from the 6 presentations
Tweet media one
1
11
48
@Gurleen_Kaur96
Gurleen Kaur, MD
2 years
1/ In Episode 180 @PaChapterACC & @CardioNerds Narratives in Cardiology episode, @PrettiPimentaMD , @ersied727 , @AmitGoyalMD , & @Dr_DanMD talk with @dranulala Follow this #CardsNarratives 🧵on the discussion about Raising Women Leaders in Academic Cardiology
Tweet media one
2
14
48
@Gurleen_Kaur96
Gurleen Kaur, MD
3 years
1/ In the latest @PaChapterACC & @CardioNerds Narratives in Cardiology episode, @pablosanchezcas , @iconsideritjoy , @AmitGoyalMD , & @Dr_DanMD talk with @HeartBobH Follow this #CardsNarratives 🧵on the discussion about Diversity and Inclusion Via Allyship and Leadership
Tweet media one
1
18
44